Optical coherence tomography angiography for detection of macular neovascularization associated with atrophy in age-related macular degeneration

• DOI: 10.1007/s00417-020-04821-6
• Publication Date: 2020-07-03T18:03:25Z
• Authors: Federico Corvi; Mariano Cozzi; Alessandro Invern...; Lucia Pace; Srinivas R. Sadda; Giovanni Staurenghi
• Keywords: Macular Degeneration; 03 medical and health sciences; 0302 clinical medicine; Humans; Prospective Studies; Fluorescein angiography; Geographic atrophy; Indocyanine green angiography; Macular atrophy; Macular neovascularization; Optical coherence tomography; Optical coherence tomography angiography; Atrophy; Fluorescein Angiography; Choroidal Neovascularization; Tomography, Optical Coherence

To evaluate the ability of optical coherence tomography angiography (OCTA) to detect macular neovascularization (MNV) in eyes with atrophy compared with fluorescein angiography (FA), indocyanine green angiography (ICGA), and optical coherence tomography (OCT).In this prospective study, eyes with MNV and atrophy (termed macular atrophy or MA) secondary to age-related macular degeneration (AMD), and AMD eyes with geographic atrophy (GA) without MNV underwent multimodal imaging with FA, ICGA, structural OCT, and OCTA. The presence of MNV was determined using all imaging modalities by senior retina specialists and was considered the gold standard reference. Each individual imaging modality was then evaluated independently by two expert readers for the presence of MNV in a masked fashion. Morphologic characteristics of the MNV were evaluated on the custom OCTA slab.Twenty-one patients with MA+MNV and 21 with GA only were enrolled. Manual segmentation on OCTA allowed detection of the MNV in 95.2% of eyes with MA+MNV and in 4.7% of eyes with GA, showing high specificity (95.2%) and sensitivity (95.2%). FA, ICGA, and OCT detected MNV in 57.1%, 52.3%, and 66.7% of eyes with MA+MNV and in 14.2%, 9.5%, and 42.8% with GA. Sensitivity and specificity were 85.7% and 57.1% for FA, 90.5% and 52.4% for ICGA, and 66.7% and 57.1% for OCT.OCTA appears to be superior to other imaging modalities for identification of MNV in eyes with macular atrophy. OCTA should be considered as part of the multimodal imaging evaluation of eyes with atrophy, particularly in the context of clinical trials.